Meet Our Venture Team
Robert Adelman, MDManaging Partner
Dr. Adelman has a 30+ year history of founding, investing in, and managing companies in the life sciences sector. Dr. Adelman received his undergraduate degree from University of California at Berkeley, his medical degree from Yale University, performed his residency at Cornell University Medical Center, and practiced surgery in New York and New Jersey.
Corey Goodman, PhDManaging Partner
Dr. Goodman is a scientist, educator, and entrepreneur. He spent 25 years as Professor of Biology at Stanford University and Evan Rauch Chair of Neurobiology at Berkeley (Dept. of Molecular and Cell Biology), where he was Howard Hughes Medical Institute Investigator, Head of the Neurobiology Division, and co-founder and Director of the Wills Neuroscience Institute.
Aaron Royston, MD, MBAPrincipal
Dr. Royston joined venBio with experience in life science venture capital, healthcare strategy, and entrepreneurship. Dr. Royston received his undergraduate degree from Duke University, his M.D. and M.B.A. degrees from the University of Pennsylvania, and coordinated clinical research at Mount Sinai Medical Center, where his research has been published and presented in multiple medical journals and conferences.
Jaume Pons, PhDVenture Partner
Dr. Pons is CEO of Alexo Therapeutics, a venture-funded Immuno-Oncology company co-founded and funded by venBio. Previously, as Senior Vice-President at Pfizer, he was Chief Scientific Officer and site head of Rinat (Pfizer) from 2007 to 2015, where he was responsible for portfolio delivery from idea to human proof of concept.